共 106 条
[1]
Osborne JP(2010)Epidemiology of tuberous sclerosis Ann N Y Acad Sci 615 125-127
[2]
Fryer A(1997)Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 Science 277 805-808
[3]
Webb D(1993)1 T S. Identification and characterization of the tuberous sclerosis gene on chromosome 16 Cell 75 1305-1315
[4]
Van SM(2007)The two TORCs and Akt Dev Cell 12 487-502
[5]
De HR(2013)Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Pediatr Neurol 49 243-254
[6]
Hermans C(2013)Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference Pediatr Neurol 49 243-95
[7]
Bhaskar PT(2006)Current development of mTOR inhibitors as anticancer agents Nat Rev Drug Discov 5 671-585
[8]
Hay N(2004)Clinical pharmacokinetics of Everolimus Clin Pharmacokinet 43 83-223
[9]
Hope N(2001)Clinical pharmacokinetics of sirolimus Clin Pharmacokinet 40 573-621
[10]
Krueger Darcy A(2013)mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain Nature 497 217-453